s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:subject	"mild to moderate acetylcholine receptor antibodypositive rituximab"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"mild"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"acetylcholine receptor"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"antibodypositive rituximab"
s6.2	"antibodypositive rituximab"	rdfs:subClassOf	"rituximab"
s6.2	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s6.2	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s6.2	"antibodypositive rituximab"	rdfs:member	"antibodypositive"
s6.2	"receptor antibodypositive rituximab"	rdfs:subClassOf	"antibodypositive rituximab"
s6.2	"acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"receptor antibodypositive rituximab"
s6.2	"moderate acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"acetylcholine receptor antibodypositive rituximab"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"mild"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"moderate acetylcholine receptor antibodypositive rituximab"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:predicate	"reduce"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:object	"steroid use absolute difference of at least 30 percent"
s6.2	"steroid use absolute difference of at least 30 percent"	rdfs:member	"steroid use"
s6.2	"steroid use absolute difference of at least 30 percent"	rdfs:member	"absolute difference"
s6.2	"steroid use absolute difference of at least 30 percent"	rdfs:member	"percent"
s6.2	"absolute difference"	rdfs:member	"absolute"
s6.2	"steroid use"	rdfs:member	"steroid"
s6.2	"absolute difference"	rdfs:subClassOf	"difference"
s6.2	"steroid use"	rdfs:subClassOf	"use"
s6.2	"30 percent"	rdfs:subClassOf	"percent"
s6.2	"least 30"	rdfs:subClassOf	"30"
s6.2	"absolute difference of 30 percent"	rdfs:member	"absolute difference"
s6.2	"absolute difference of 30 percent"	rdfs:member	"30 percent"
s6.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	local:AM-TMP	"1 year"
s6.2	"1 year"	rdfs:subClassOf	"year"
s6.1	"evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s6.1	"evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:subject	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"steroid use"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"antibodypositive rituximab"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"year"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"absolute difference"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"mild"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"acetylcholine receptor"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"percent"
s6.1	"antibodypositive rituximab"	rdfs:subClassOf	"rituximab"
s6.1	"absolute difference"	rdfs:subClassOf	"difference"
s6.1	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s6.1	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s6.1	"steroid use"	rdfs:member	"steroid"
s6.1	"absolute difference"	rdfs:member	"absolute"
s6.1	"antibodypositive rituximab"	rdfs:member	"antibodypositive"
s6.1	"steroid use"	rdfs:subClassOf	"use"
s6.1	"1 year"	rdfs:subClassOf	"year"
s6.1	"30 percent"	rdfs:subClassOf	"percent"
s6.1	"least 30"	rdfs:subClassOf	"30"
s6.1	"receptor antibodypositive rituximab"	rdfs:subClassOf	"antibodypositive rituximab"
s6.1	"acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"receptor antibodypositive rituximab"
s6.1	"moderate acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"acetylcholine receptor antibodypositive rituximab"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"mild"
s6.1	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"moderate acetylcholine receptor antibodypositive rituximab"
s6.1	"reduce by absolute difference"	rdfs:member	"reduce"
s6.1	"reduce by absolute difference"	rdfs:member	"absolute difference"
s6.1	"absolute difference of 30 percent"	rdfs:member	"absolute difference"
s6.1	"absolute difference of 30 percent"	rdfs:member	"30 percent"
s6.1	"reduce by absolute difference at 1 year"	rdfs:member	"reduce by absolute difference"
s6.1	"reduce by absolute difference at 1 year"	rdfs:member	"1 year"
s6.1	"evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:predicate	"evidence"
s6	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s6	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:subject	"study"
s6	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:predicate	"provide"
s6	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:object	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s6	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"steroid use"
s6	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"antibodypositive rituximab"
s6	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"year"
s6	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"class i evidence"
s6	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"absolute difference"
s6	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"mild"
s6	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"acetylcholine receptor"
s6	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be safe to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"percent"
s6	"antibodypositive rituximab"	rdfs:subClassOf	"rituximab"
s6	"absolute difference"	rdfs:subClassOf	"difference"
s6	"class i"	rdfs:member	"class"
s6	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s6	"i evidence"	rdfs:subClassOf	"evidence"
s6	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s6	"steroid use"	rdfs:member	"steroid"
s6	"absolute difference"	rdfs:member	"absolute"
s6	"antibodypositive rituximab"	rdfs:member	"antibodypositive"
s6	"class i evidence"	rdfs:member	"class i"
s6	"steroid use"	rdfs:subClassOf	"use"
s6	"class i"	rdfs:subClassOf	"i"
s6	"class i evidence"	rdfs:subClassOf	"evidence"
s6	"i evidence"	rdfs:member	"i"
s6	"1 year"	rdfs:subClassOf	"year"
s6	"30 percent"	rdfs:subClassOf	"percent"
s6	"least 30"	rdfs:subClassOf	"30"
s6	"receptor antibodypositive rituximab"	rdfs:subClassOf	"antibodypositive rituximab"
s6	"acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"receptor antibodypositive rituximab"
s6	"moderate acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"acetylcholine receptor antibodypositive rituximab"
s6	"class i evidence"	rdfs:subClassOf	"i evidence"
s6	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"mild"
s6	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"moderate acetylcholine receptor antibodypositive rituximab"
s6	"reduce by absolute difference"	rdfs:member	"reduce"
s6	"reduce by absolute difference"	rdfs:member	"absolute difference"
s6	"absolute difference of 30 percent"	rdfs:member	"absolute difference"
s6	"absolute difference of 30 percent"	rdfs:member	"30 percent"
s6	"reduce by absolute difference at 1 year"	rdfs:member	"reduce by absolute difference"
s6	"reduce by absolute difference at 1 year"	rdfs:member	"1 year"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:subject	"mild to moderate acetylcholine receptor antibodypositive rituximab"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"mild"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"acetylcholine receptor"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"antibodypositive rituximab"
s5.2	"antibodypositive rituximab"	rdfs:subClassOf	"rituximab"
s5.2	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s5.2	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s5.2	"antibodypositive rituximab"	rdfs:member	"antibodypositive"
s5.2	"receptor antibodypositive rituximab"	rdfs:subClassOf	"antibodypositive rituximab"
s5.2	"acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"receptor antibodypositive rituximab"
s5.2	"moderate acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"acetylcholine receptor antibodypositive rituximab"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"mild"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"moderate acetylcholine receptor antibodypositive rituximab"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:predicate	"reduce"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:object	"steroid use absolute difference of at least 30 percent"
s5.2	"steroid use absolute difference of at least 30 percent"	rdfs:member	"steroid use"
s5.2	"steroid use absolute difference of at least 30 percent"	rdfs:member	"absolute difference"
s5.2	"steroid use absolute difference of at least 30 percent"	rdfs:member	"percent"
s5.2	"absolute difference"	rdfs:member	"absolute"
s5.2	"steroid use"	rdfs:member	"steroid"
s5.2	"absolute difference"	rdfs:subClassOf	"difference"
s5.2	"steroid use"	rdfs:subClassOf	"use"
s5.2	"30 percent"	rdfs:subClassOf	"percent"
s5.2	"least 30"	rdfs:subClassOf	"30"
s5.2	"absolute difference of 30 percent"	rdfs:member	"absolute difference"
s5.2	"absolute difference of 30 percent"	rdfs:member	"30 percent"
s5.2	"mild to moderate acetylcholine receptor antibodypositive rituximab reduce steroid use by an absolute difference of at least 30 percent at 1 year"	local:AM-TMP	"1 year"
s5.2	"1 year"	rdfs:subClassOf	"year"
s5.1	"evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s5.1	"evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:subject	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"steroid use"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"antibodypositive rituximab"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"year"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"absolute difference"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"mild"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"acetylcholine receptor"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"percent"
s5.1	"antibodypositive rituximab"	rdfs:subClassOf	"rituximab"
s5.1	"absolute difference"	rdfs:subClassOf	"difference"
s5.1	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s5.1	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s5.1	"steroid use"	rdfs:member	"steroid"
s5.1	"absolute difference"	rdfs:member	"absolute"
s5.1	"antibodypositive rituximab"	rdfs:member	"antibodypositive"
s5.1	"steroid use"	rdfs:subClassOf	"use"
s5.1	"1 year"	rdfs:subClassOf	"year"
s5.1	"30 percent"	rdfs:subClassOf	"percent"
s5.1	"least 30"	rdfs:subClassOf	"30"
s5.1	"receptor antibodypositive rituximab"	rdfs:subClassOf	"antibodypositive rituximab"
s5.1	"acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"receptor antibodypositive rituximab"
s5.1	"moderate acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"acetylcholine receptor antibodypositive rituximab"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"mild"
s5.1	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"moderate acetylcholine receptor antibodypositive rituximab"
s5.1	"reduce by absolute difference"	rdfs:member	"reduce"
s5.1	"reduce by absolute difference"	rdfs:member	"absolute difference"
s5.1	"absolute difference of 30 percent"	rdfs:member	"absolute difference"
s5.1	"absolute difference of 30 percent"	rdfs:member	"30 percent"
s5.1	"reduce by absolute difference at 1 year"	rdfs:member	"reduce by absolute difference"
s5.1	"reduce by absolute difference at 1 year"	rdfs:member	"1 year"
s5.1	"evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:predicate	"evidence"
s5	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s5	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:subject	"study"
s5	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:predicate	"provide"
s5	"this study provides class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab is unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdf:object	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"
s5	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"steroid use"
s5	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"antibodypositive rituximab"
s5	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"year"
s5	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"class i evidence"
s5	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"absolute difference"
s5	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"mild"
s5	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"acetylcholine receptor"
s5	"class i evidence that for mild to moderate acetylcholine receptor antibodypositive rituximab be unlikely to reduce steroid use by an absolute difference of at least 30 percent at 1 year"	rdfs:member	"percent"
s5	"antibodypositive rituximab"	rdfs:subClassOf	"rituximab"
s5	"absolute difference"	rdfs:subClassOf	"difference"
s5	"class i"	rdfs:member	"class"
s5	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s5	"i evidence"	rdfs:subClassOf	"evidence"
s5	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s5	"steroid use"	rdfs:member	"steroid"
s5	"absolute difference"	rdfs:member	"absolute"
s5	"antibodypositive rituximab"	rdfs:member	"antibodypositive"
s5	"class i evidence"	rdfs:member	"class i"
s5	"steroid use"	rdfs:subClassOf	"use"
s5	"class i"	rdfs:subClassOf	"i"
s5	"class i evidence"	rdfs:subClassOf	"evidence"
s5	"i evidence"	rdfs:member	"i"
s5	"1 year"	rdfs:subClassOf	"year"
s5	"30 percent"	rdfs:subClassOf	"percent"
s5	"least 30"	rdfs:subClassOf	"30"
s5	"receptor antibodypositive rituximab"	rdfs:subClassOf	"antibodypositive rituximab"
s5	"acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"receptor antibodypositive rituximab"
s5	"moderate acetylcholine receptor antibodypositive rituximab"	rdfs:subClassOf	"acetylcholine receptor antibodypositive rituximab"
s5	"class i evidence"	rdfs:subClassOf	"i evidence"
s5	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"mild"
s5	"mild to moderate acetylcholine receptor antibodypositive rituximab"	rdfs:member	"moderate acetylcholine receptor antibodypositive rituximab"
s5	"reduce by absolute difference"	rdfs:member	"reduce"
s5	"reduce by absolute difference"	rdfs:member	"absolute difference"
s5	"absolute difference of 30 percent"	rdfs:member	"absolute difference"
s5	"absolute difference of 30 percent"	rdfs:member	"30 percent"
s5	"reduce by absolute difference at 1 year"	rdfs:member	"reduce by absolute difference"
s5	"reduce by absolute difference at 1 year"	rdfs:member	"1 year"
s4	"mild to moderate acetylcholine receptor antibodypositive generalized myasthenia gravis compared with placebo"
s4	"mild to moderate acetylcholine receptor antibodypositive generalized myasthenia gravis compared with placebo"	rdf:subject	"mild to moderate acetylcholine receptor antibodypositive generalize myasthenia gravis"
s4	"mild to moderate acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"antibodypositive generalize myasthenia gravis"
s4	"mild to moderate acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"mild"
s4	"mild to moderate acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"acetylcholine receptor"
s4	"antibodypositive generalize myasthenia"	rdfs:member	"antibodypositive generalize"
s4	"generalize myasthenia gravis"	rdfs:subClassOf	"gravis"
s4	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s4	"myasthenia gravis"	rdfs:member	"myasthenia"
s4	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s4	"generalize myasthenia"	rdfs:member	"generalize"
s4	"antibodypositive generalize myasthenia"	rdfs:subClassOf	"myasthenia"
s4	"antibodypositive generalize myasthenia gravis"	rdfs:member	"antibodypositive generalize myasthenia"
s4	"antibodypositive generalize myasthenia gravis"	rdfs:subClassOf	"gravis"
s4	"generalize myasthenia"	rdfs:subClassOf	"myasthenia"
s4	"generalize myasthenia gravis"	rdfs:member	"generalize myasthenia"
s4	"antibodypositive generalize"	rdfs:member	"antibodypositive"
s4	"myasthenia gravis"	rdfs:subClassOf	"gravis"
s4	"antibodypositive generalize"	rdfs:subClassOf	"generalize"
s4	"antibodypositive generalize myasthenia"	rdfs:subClassOf	"generalize myasthenia"
s4	"moderate acetylcholine receptor"	rdfs:subClassOf	"acetylcholine receptor"
s4	"mild to moderate acetylcholine receptor"	rdfs:member	"mild"
s4	"mild to moderate acetylcholine receptor"	rdfs:member	"moderate acetylcholine receptor"
s4	"mild to moderate acetylcholine receptor antibodypositive generalized myasthenia gravis compared with placebo"	rdf:predicate	"compare"
s4	"mild to moderate acetylcholine receptor antibodypositive generalized myasthenia gravis compared with placebo"	rdf:object	"placebo"
s3.1	"observing this study"
s3.1	"observing this study"	rdf:subject	"study"
s3.1	"observing this study"	rdf:predicate	"observe"
s3	"rituximab was safe these results suggest that there is a low probability of observing this study"
s3	"rituximab was safe these results suggest that there is a low probability of observing this study"	rdf:subject	"rituximab be safe these result"
s3	"rituximab be safe these result"	rdfs:member	"rituximab"
s3	"rituximab be safe these result"	rdfs:member	"result"
s3	"result safe"	rdfs:subClassOf	"safe"
s3	"rituximab was safe these results suggest that there is a low probability of observing this study"	rdf:predicate	"suggest"
s3	"rituximab was safe these results suggest that there is a low probability of observing this study"	rdf:object	"low probability of observe this study"
s3	"low probability of observe this study"	rdfs:member	"low probability"
s3	"low probability of observe this study"	rdfs:member	"study"
s3	"low probability of observe this study"	rdfs:member	"observe"
s3	"low probability"	rdfs:subClassOf	"probability"
s3	"low probability"	rdfs:member	"low"
s2.2	"observing this study"
s2.2	"observing this study"	rdf:subject	"study"
s2.2	"observing this study"	rdf:predicate	"observe"
s2.1	"these results suggest that there is a low probability of observing this study"
s2.1	"these results suggest that there is a low probability of observing this study"	rdf:subject	"result"
s2.1	"these results suggest that there is a low probability of observing this study"	rdf:predicate	"suggest"
s2.1	"these results suggest that there is a low probability of observing this study"	rdf:object	"low probability of observe this study"
s2.1	"low probability of observe this study"	rdfs:member	"low probability"
s2.1	"low probability of observe this study"	rdfs:member	"study"
s2.1	"low probability of observe this study"	rdfs:member	"observe"
s2.1	"low probability"	rdfs:subClassOf	"probability"
s2.1	"low probability"	rdfs:member	"low"
s2	"rituximab welltolerated these results"
s2	"rituximab welltolerated these results"	rdf:subject	"rituximab"
s2	"rituximab welltolerated these results"	rdf:predicate	"welltolerated"
s2	"rituximab welltolerated these results"	rdf:object	"result"
s1.1	"rituximab warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"
s1.1	"rituximab warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	rdf:subject	"rituximab"
s1.1	"rituximab warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	rdf:predicate	"warrant"
s1.1	"rituximab warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	rdf:object	"investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"
s1.1	"investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"antibodypositive generalize myasthenia gravis"
s1.1	"investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"efficacy trial"
s1.1	"investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"investigation"
s1.1	"investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"acetylcholine receptor"
s1.1	"efficacy trial"	rdfs:member	"efficacy"
s1.1	"antibodypositive generalize myasthenia"	rdfs:member	"antibodypositive generalize"
s1.1	"generalize myasthenia gravis"	rdfs:subClassOf	"gravis"
s1.1	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s1.1	"myasthenia gravis"	rdfs:member	"myasthenia"
s1.1	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s1.1	"generalize myasthenia"	rdfs:member	"generalize"
s1.1	"antibodypositive generalize myasthenia"	rdfs:subClassOf	"myasthenia"
s1.1	"antibodypositive generalize myasthenia gravis"	rdfs:member	"antibodypositive generalize myasthenia"
s1.1	"antibodypositive generalize myasthenia gravis"	rdfs:subClassOf	"gravis"
s1.1	"generalize myasthenia"	rdfs:subClassOf	"myasthenia"
s1.1	"generalize myasthenia gravis"	rdfs:member	"generalize myasthenia"
s1.1	"antibodypositive generalize"	rdfs:member	"antibodypositive"
s1.1	"myasthenia gravis"	rdfs:subClassOf	"gravis"
s1.1	"antibodypositive generalize"	rdfs:subClassOf	"generalize"
s1.1	"efficacy trial"	rdfs:subClassOf	"trial"
s1.1	"antibodypositive generalize myasthenia"	rdfs:subClassOf	"generalize myasthenia"
s1.1	"investigation in efficacy trial"	rdfs:member	"investigation"
s1.1	"investigation in efficacy trial"	rdfs:member	"efficacy trial"
s1.1	"efficacy trial for acetylcholine receptor"	rdfs:member	"efficacy trial"
s1.1	"efficacy trial for acetylcholine receptor"	rdfs:member	"acetylcholine receptor"
s1	"determine whether rituximab is safe warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"
s1	"determine whether rituximab is safe warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	rdf:subject	"whether rituximab be safe warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"
s1	"whether rituximab be safe warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"further investigation"
s1	"whether rituximab be safe warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"efficacy trial"
s1	"whether rituximab be safe warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"rituximab"
s1	"whether rituximab be safe warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"safe warrant"
s1	"whether rituximab be safe warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"antibodypositive generalize myasthenia gravis"
s1	"whether rituximab be safe warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"acetylcholine receptor"
s1	"efficacy trial"	rdfs:member	"efficacy"
s1	"generalize myasthenia gravis"	rdfs:subClassOf	"gravis"
s1	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s1	"generalize myasthenia gravis"	rdfs:member	"generalize myasthenia"
s1	"safe warrant"	rdfs:subClassOf	"warrant"
s1	"further investigation"	rdfs:member	"further"
s1	"antibodypositive generalize"	rdfs:subClassOf	"generalize"
s1	"further investigation"	rdfs:subClassOf	"investigation"
s1	"antibodypositive generalize myasthenia"	rdfs:member	"antibodypositive generalize"
s1	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s1	"myasthenia gravis"	rdfs:member	"myasthenia"
s1	"generalize myasthenia"	rdfs:member	"generalize"
s1	"antibodypositive generalize myasthenia gravis"	rdfs:member	"antibodypositive generalize myasthenia"
s1	"antibodypositive generalize myasthenia gravis"	rdfs:subClassOf	"gravis"
s1	"safe warrant"	rdfs:member	"safe"
s1	"efficacy trial"	rdfs:subClassOf	"trial"
s1	"antibodypositive generalize myasthenia"	rdfs:subClassOf	"myasthenia"
s1	"generalize myasthenia"	rdfs:subClassOf	"myasthenia"
s1	"antibodypositive generalize"	rdfs:member	"antibodypositive"
s1	"myasthenia gravis"	rdfs:subClassOf	"gravis"
s1	"antibodypositive generalize myasthenia"	rdfs:subClassOf	"generalize myasthenia"
s1	"further investigation in efficacy trial"	rdfs:member	"further investigation"
s1	"further investigation in efficacy trial"	rdfs:member	"efficacy trial"
s1	"efficacy trial for acetylcholine receptor"	rdfs:member	"efficacy trial"
s1	"efficacy trial for acetylcholine receptor"	rdfs:member	"acetylcholine receptor"
s1	"determine whether rituximab is safe warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	rdf:predicate	"determine"
s0	"determine whether rituximab is potentially beneficial warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"
s0	"determine whether rituximab is potentially beneficial warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	rdf:subject	"whether rituximab be potentially beneficial warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"
s0	"whether rituximab be potentially beneficial warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"potentially beneficial warrant"
s0	"whether rituximab be potentially beneficial warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"further investigation"
s0	"whether rituximab be potentially beneficial warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"efficacy trial"
s0	"whether rituximab be potentially beneficial warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"rituximab"
s0	"whether rituximab be potentially beneficial warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"antibodypositive generalize myasthenia gravis"
s0	"whether rituximab be potentially beneficial warrant further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalize myasthenia gravis"	rdfs:member	"acetylcholine receptor"
s0	"efficacy trial"	rdfs:member	"efficacy"
s0	"generalize myasthenia gravis"	rdfs:subClassOf	"gravis"
s0	"acetylcholine receptor"	rdfs:member	"acetylcholine"
s0	"generalize myasthenia gravis"	rdfs:member	"generalize myasthenia"
s0	"potentially beneficial warrant"	rdfs:member	"potentially beneficial"
s0	"further investigation"	rdfs:member	"further"
s0	"antibodypositive generalize"	rdfs:subClassOf	"generalize"
s0	"further investigation"	rdfs:subClassOf	"investigation"
s0	"potentially beneficial"	rdfs:subClassOf	"beneficial"
s0	"antibodypositive generalize myasthenia"	rdfs:member	"antibodypositive generalize"
s0	"acetylcholine receptor"	rdfs:subClassOf	"receptor"
s0	"myasthenia gravis"	rdfs:member	"myasthenia"
s0	"generalize myasthenia"	rdfs:member	"generalize"
s0	"antibodypositive generalize myasthenia gravis"	rdfs:member	"antibodypositive generalize myasthenia"
s0	"antibodypositive generalize myasthenia gravis"	rdfs:subClassOf	"gravis"
s0	"beneficial warrant"	rdfs:member	"beneficial"
s0	"efficacy trial"	rdfs:subClassOf	"trial"
s0	"beneficial warrant"	rdfs:subClassOf	"warrant"
s0	"potentially beneficial warrant"	rdfs:subClassOf	"warrant"
s0	"antibodypositive generalize myasthenia"	rdfs:subClassOf	"myasthenia"
s0	"generalize myasthenia"	rdfs:subClassOf	"myasthenia"
s0	"antibodypositive generalize"	rdfs:member	"antibodypositive"
s0	"myasthenia gravis"	rdfs:subClassOf	"gravis"
s0	"potentially beneficial"	rdfs:member	"potentially"
s0	"antibodypositive generalize myasthenia"	rdfs:subClassOf	"generalize myasthenia"
s0	"further investigation in efficacy trial"	rdfs:member	"further investigation"
s0	"further investigation in efficacy trial"	rdfs:member	"efficacy trial"
s0	"efficacy trial for acetylcholine receptor"	rdfs:member	"efficacy trial"
s0	"efficacy trial for acetylcholine receptor"	rdfs:member	"acetylcholine receptor"
s0	"determine whether rituximab is potentially beneficial warranting further investigation in an efficacy trial for acetylcholine receptor antibodypositive generalized myasthenia gravis"	rdf:predicate	"determine"
